LINE

Text:AAAPrint
Sci-tech

Diabetes drug may help prevent blindness: study

1
2018-10-29 22:52:24Xinhua Editor : Wang Fan ECNS App Download

Researchers from China's Taiwan Province have found that a common drug used to treat type 2 diabetes may have an effect of lowering the possibility of developing a disease leading to blindness, the American Academy of Ophthalmology (AAO) said Sunday.

The San Francisco-based academy said the research, disclosed at AAO 2018, its 122nd Annual Meeting being held in Chicago from Oct. 27 to Oct. 30, showed the diabetes patients who took the medication of metformin have a significant lower rate of developing age-related macular degeneration (AMD), one of the leading causes of blindness in Americans aged 50 or above.

The researchers studied the statistics of the health insurance research database in Taiwan from a period spanning from 2001 and 2013 and found that 45,524 type 2 diabetes patients who took metformin have better chances to avoid suffering AMD that affects about 2.1 million people in the United States.

The study suggests that metformin, which controls the blood glucose level in type 2 diabetes patients, can suppress inflammation and oxidative stress, the two major factors that play a key role in the development of both diabetes and AMD.

"Our study is the first to reveal the protective effect of metformin on the development of AMD," said lead investigator Yu-Yen Chen.

The AAO is the world's largest association of eye physicians and surgeons, with a global community of 32,000 medical doctors, which is committed to advocating the protection of sight and empowering lives by promoting eye care and health for the public.

 

  

MorePhoto

Most popular in 24h

MoreTop news

MoreVideo

News
Politics
Business
Society
Culture
Military
Sci-tech
Entertainment
Sports
Odd
Features
Biz
Economy
Travel
Travel News
Travel Types
Events
Food
Hotel
Bar & Club
Architecture
Gallery
Photo
CNS Photo
Video
Video
Learning Chinese
Learn About China
Social Chinese
Business Chinese
Buzz Words
Bilingual
Resources
ECNS Wire
Special Coverage
Infographics
Voices
LINE
Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2018 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.